IRIS
MEROLA, Elettra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.263
AS - Asia 1.875
SA - Sud America 1.564
EU - Europa 936
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 88
OC - Oceania 1
Totale 12.862
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.092
BR - Brasile 1.257
VN - Vietnam 636
IT - Italia 532
SG - Singapore 458
CN - Cina 245
HK - Hong Kong 243
AR - Argentina 143
FR - Francia 96
CA - Canada 65
DE - Germania 60
ID - Indonesia 59
EC - Ecuador 52
GB - Regno Unito 52
BD - Bangladesh 51
MX - Messico 46
RU - Federazione Russa 45
IN - India 42
PY - Paraguay 28
CO - Colombia 27
ZA - Sudafrica 27
IQ - Iraq 25
FI - Finlandia 21
ES - Italia 20
UA - Ucraina 18
AT - Austria 17
VE - Venezuela 15
CL - Cile 14
PK - Pakistan 14
NL - Olanda 13
PL - Polonia 13
MA - Marocco 12
SE - Svezia 12
JP - Giappone 11
PE - Perù 11
TR - Turchia 11
EG - Egitto 10
KZ - Kazakistan 10
TN - Tunisia 10
UZ - Uzbekistan 10
SV - El Salvador 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
DO - Repubblica Dominicana 8
JM - Giamaica 8
SA - Arabia Saudita 8
RO - Romania 7
JO - Giordania 6
KE - Kenya 6
NP - Nepal 6
OM - Oman 6
ET - Etiopia 5
GT - Guatemala 5
IL - Israele 5
LT - Lituania 5
NI - Nicaragua 5
PR - Porto Rico 5
AZ - Azerbaigian 4
BB - Barbados 4
CR - Costa Rica 4
DZ - Algeria 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
HN - Honduras 3
IE - Irlanda 3
LB - Libano 3
RS - Serbia 3
SY - Repubblica araba siriana 3
DK - Danimarca 2
KW - Kuwait 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
Totale 12.721
Salva come PNG Salva come JPEG
Città #
Dallas 6.052
San Jose 358
Ashburn 316
Ho Chi Minh City 261
Council Bluffs 246
Hong Kong 238
Santa Clara 143
Hanoi 138
Singapore 113
Columbus 106
São Paulo 97
Beijing 89
Milan 87
Lauterbourg 80
Rome 67
Los Angeles 65
Phoenix 53
Rio de Janeiro 46
The Villages 42
New York 41
Naples 30
Buenos Aires 27
Brasília 26
Haiphong 25
Orem 23
Buffalo 21
Chicago 21
Curitiba 21
Montreal 21
Miano 19
Turin 19
Campinas 18
Quito 18
Atlanta 17
Belo Horizonte 17
Mexico City 17
Munich 17
Da Nang 15
Hải Dương 15
Bologna 14
Guayaquil 14
Thái Bình 14
Caxias do Sul 13
Johannesburg 13
Montebello 13
Warsaw 13
Biên Hòa 12
Fortaleza 12
Guarulhos 12
Ninh Bình 12
Porto Alegre 12
Uberlândia 12
Asunción 11
Catania 11
Denver 11
Düsseldorf 11
Frankfurt am Main 11
Goiânia 11
Helsinki 11
Houston 11
Juiz de Fora 11
Nuremberg 11
Baghdad 10
Bắc Giang 10
Niterói 10
Osasco 10
Stockholm 10
Tokyo 10
Toronto 10
Turku 10
Chennai 9
Dhaka 9
Manchester 9
Piracicaba 9
Poplar 9
Ribeirão Preto 9
Salvador 9
San Francisco 9
Trento 9
Vienna 9
Amsterdam 8
Boston 8
Contagem 8
Florence 8
Jakarta 8
London 8
Madrid 8
Santa Maria 8
Thái Nguyên 8
Americana 7
Brooklyn 7
Can Tho 7
Córdoba 7
Genoa 7
Ha Long 7
Ipatinga 7
Lima 7
Manaus 7
Marília 7
Montevideo 7
Totale 9.620
Salva come PNG Salva come JPEG
Nome #
Artificial intelligence in the diagnosis of gastro‐entero‐pancreatic neuroendocrine neoplasms: Potential benefits and current limitations 608
HETEROGENEITY OF TYPE 1 GASTRIC NEUROENDOCRINE NEOPLASMS 368
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 365
Reassessment of Proliferative Activity at Disease Progression in Neuroendocrine Neoplasms 361
Curative Resection in Digestive Neuroendocrine Neoplasms: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 356
Clinical Usefulness of Functional Imaging Tests in the Follow-Up of Digestive Neuroendocrine Neoplasms 352
Contrast Enhanced Ultrasonography (CEUS) and Quantitative Perfusion Analysis in the Assessment of Neuroendocrine Liver Metastases 351
FOLFOX Chemotherapy: Efficacy and Tolerability in Advanced Digestive Neuroendocrine Neoplasms (NENs) 351
Accuracy of the Novel TNM Staging System in the Prognostic Stratification of Patients With Advanced, Stage IV Digestive Endocrine Tumors 345
Peritoneal Carcinomatosis in Digestive Neuroendocrine Neoplasms: Complications and Response to Therapy 342
Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 341
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 339
Evaluation of Multidisciplinary Tumor Board Decisions in the Management of Neuroendocrine Tumors: Impact of Expert Centers 336
Role of Somatostatin Receptors scintigraphy in neuroendocrine neoplasms follow-up 335
REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS 332
Risk and Protective Factors for Midgut Carcinoid Tumours: Multicenter Case-Control Study of Prospectively Evaluated Patients 323
Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients 320
Histopathological Revision forGastroenteropancreatic NeuroendocrineNeoplasms in Expert Centers: Does It Make theDifference? 314
Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 311
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate 270
Curative resection in digestive neuroendocrine neoplasms: Recurrence-free survival rate and definition of a risk score for recurrence 268
- Lineeguida AIOM-ITANET “Neoplasie Neuroendocrine gastroenteropancreatiche”; edizione 2015 198
Artificial Intelligence for Prognosis of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 149
P53 and the malignant progression of Barrett's esophagus 117
ASO Author Reflection: Risk of Recurrence After Radical Resection in Entero-Pancreatic Neuroendocrine Tumors 111
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms 109
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 107
Adverse events in gastrointestinal endoscopy: Validation of the AGREE classification in a real-life 5-year setting 106
Appendiceal collision tumors: case reports, management and literature review 102
Cap-assisted EMR for large colorectal laterally spreading tumors: a cautionary tale from real-life experience 101
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis 99
Chromogranin A in the Follow-Up of Digestive Neuroendocrine Neoplasms: Is It a Useful Biomarker? 98
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid 92
Cap-assisted endoscopic mucosal resection as a salvage technique for challenging colorectal laterally spreading tumors 91
Commentary: Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis 90
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate 86
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome 85
Portosystemic encephalopathy in an 86-year-old patient : a clinical challenge 85
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 84
Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications 83
Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres 83
Two-devices-in-one-channel technique for precut sphincterotomy 83
TYPE I GASTRIC CARCINOIDS: A PROSPECTIVE STUDY ON ENDOSCOPICMANAGEMENT AND RECURRENCE RATE 82
Nasogastric or nasointestinal feeding in severe acute pancreatitis 80
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 79
Neuroendocrine tumors 79
Role of impaired epithelial barrier of esophageal body and of proximal reflux in the pathophysiology of non-erosive gastroesophageal reflux disease 79
Stage IV gastro-entero-pancreatic neuroendocrine neoplasms. A risk score to predict clinical outcome 77
Role of ACE1, ACE2, and CCR5-Δ32 Polymorphisms in the Transmission of SARS-CoV-2 to Intimate Contacts 77
Efficacy and Toxicity of 5-Fluorouracil-Oxaliplatin in Gastroenteropancreatic Neuroendocrine Neoplasms 76
Device-assisted enteroscopy: Are we ready to dismiss the spiral? 75
Functional Imaging Tests versus Computed Tomography Scan: Detection of New Metastases and Clinical Usefulness in Digestive Neuroendocrine Neoplasms Follow-Up 75
Prevalence of gastrointestinal symptoms in coronavirus disease 2019: a meta-analysis 74
Prevalence of liver injury in patients with coronavirus disease 2019 (COVID-19) : a systematic review and meta-analysis 74
Advances and future perspectives in the pharmacological treatment of Helicobacter pylori infection: Taking advantage from artificial intelligence 73
ENDOSCOPIC DIAGNOSIS OF NEUROENDOCRINE NEOPLASMS: A REAL-WORLD EXPERIENCE 73
Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21 waf-1, p27, and PCNA in Barrett's esophagus 73
Hepatitis C virus burden: Treating and educating people without prejudice 73
Pre-Endoscopy real-time PCR testing for SARS-CoV2 does not reduce health care workers infection and is associated with a higher reduction of endoscopic activity in an outpatient setting 73
Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements 73
DIAGNOSTICS OF HEREDITARY COLORECTAL CANCER SYNDROMES: A REAL-WORLD EXPERIENCE 72
Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives 72
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 71
Sequential Therapies in Well-Differentiated Gastrointestinal Neuroendocrine Tumors G3 (NET G3): Platinum-Based vs. Platinum-Free Regimens 70
Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3) 70
Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options 70
High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intent 70
Role of intraoperative enteroscopy in the management of obscure gastrointestinal bleeding 67
Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective 65
Optimal timing of endoscopy for acute upper gastrointestinal bleeding: a systematic review and meta-analysis 64
Digestive neuroendocrine neoplasms: A 2016 overview 64
Treatment of Pancreatic Neuroendocrine Tumors 64
Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference? 64
Probiotics and severe acute pancreatitis. Addendum 63
Molecular Pathology of Pancreatic Endocrine Tumors 63
Probiotics and severe acute pancreatitis 63
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 62
Bone metastases from neuroendocrine neoplasms: Resultsof an Italian nationwide survey of natural historyand management 59
Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature 59
Recurrence rates after piecemeal endoscopic mucosal resection of large colorectal laterally spreading tumors 58
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? 54
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms 53
Glucose-6-Phosphate Dehydrogenase Deficiency and Cardiovascular Risk in Familial Hypercholesterolemia: A Retrospective Cohort Study 51
PuraStat for gastrointestinal bleeding management: Effective approach for endoscopic prevention and rescue therapy 49
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High-Dosage L. reuteri in H. pylori-Infected Adults 49
Helicobacter pylori and Cancer: What’s the Link? 44
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 43
P0377 Dual-Energy and Photon-Counting Computed Tomography in Crohn’s Disease: Towards Quantitative Imaging Biomarkers. A Systematic Review 42
Educational Materials for Helicobacter pylori Infection: A Comparative Evaluation of Large Language Models Versus Human Experts 38
Predicting the Unpredictable: AI-Driven Prognosis in Pancreatic Neuroendocrine Neoplasms 38
Comment on: "Man Plus Machine: A Randomized Control Trial of Artificial Intelligence Including the Impact of Adjunctive Polyp Detection Techniques" 38
Persistence of the APOE ε4 Allele Among Sardinian Nonagenarians: Longitudinal Survival Evidence from a Blue Zone Cohort 37
High-grade gastro-entero-pancreatic neuroendocrine neoplasms: An overlooked population in interventional clinical trials. A systematic review 36
Artificial Intelligence as a Safeguard for Clinical Scientific Integrity: A Human–AI Hybrid Model for Medical Peer Review 29
Pancreatic Injuries: What Should Trauma Radiologists Know in 2026? 28
Rectal mixed adenoma-neuroendocrine lesion: a rare case report 22
Interventional Clinical Trials in Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Systematic Review of Prospective, Interventional Trials 20
The missing evidence: Stricturing Crohn's disease in clinical trials, a systematic review 18
General anesthesia with intubation and emergency endoscopy outcomes in patients with upper gastrointestinal bleeding: an inverse probability of treatment weighting study 14
Helicobacter pylori infection and neurological disorders: association, mechanisms, and clinical implications 14
Totale 12.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.191
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025944 0 0 0 0 0 0 0 0 0 749 97 98
2025/202610.136 325 3.316 3.510 1.584 245 219 303 147 164 167 127 29
2026/20271.782 117 384 465 816 0 0 0 0 0 0 0 0
Totale 12.862